Clinical Trial Update: Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of migalastat HCl (AT1001) in healthy subjects and in subjects with impaired renal function, in Fabry disease, complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Migalastat HCl (migalastat)

Snippet

Sponsor: Amicus Therapeutics | Conditions: Fabry Disease | Phase 1 | Status: COMPLETED